Ofer Levy, MD, PhD

Director, Precision Vaccines Program
Boston Children's Hospital/Harvard Medical School/Broad Institute of MIT and Harvard

Disclosure(s): No financial relationships to disclose

Poster(s):

• 1174 - Liposomal Co-Formulation of MPL and QS-21 Favors the Development of T-helper 1 Cells and Promotes the Induction of CD8+ T Cells Against SARS-CoV-2
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET